AEHR TEST SYSTEMS

Company Overview

Aehr Test Systems designs and sells platform-based test and burn‑in equipment for wafer, singulated die and packaged‑part screening, serving mission‑critical end markets such as AI accelerators, SiC/GaN EV power devices, silicon photonics, memory/storage and automotive semiconductors. Fiscal 2025 revenue was $59.0M with ~66% from wafer contact products and 34% from packaged‑part systems (EV/power = 41% of revenue); backlog was $15.2M at May 30, 2025. The company emphasizes modular, high‑parallelism platforms (FOX family, WaferPak, DiePak), outsources many components while assembling in Fremont, CA, and relies on a small but R&D‑intensive workforce and a portfolio of patents and proprietary software. Key risks include very high customer concentration (top five customers = 77%), semiconductor market cyclicality (notably EV power softness), and integration/ amortization impacts from the Incal acquisition.

Executive Compensation Practices

Given Aehr’s small scale, high R&D intensity (R&D ~17.7% of FY25 revenue and rising) and constrained cash, executive pay is likely balanced toward equity incentives (RSUs/options) and performance‑based awards rather than large cash bonuses to conserve liquidity; filings cite materially higher stock‑based compensation. Short‑term incentive metrics at a company like this commonly include revenue, bookings/backlog, gross margin or operating cash flow — all of which moved materially in FY25/Q1 and drove management commentary — while long‑term pay will likely target product development milestones, successful Incal integration, IP protection/enforcement outcomes, and multi‑year service or recurring revenue growth. Acquisition‑related retention awards, restructuring‑linked severance and milestone earnouts are plausible given the Incal deal and recent consolidation actions; amortization and acquisition charges that depressed margins also create pressure to tie pay to margin recovery and cash generation. Because management repeatedly highlighted working capital and cash sufficiency for 12 months, expect continued emphasis on cost control and non‑cash (equity) compensation to align retention with long‑term value creation.

Insider Trading Considerations

Insider trades at Aehr can convey meaningful information because of the company’s small market cap, concentrated insider ownership, and a relatively thin float—even modest insider buys or sells may move the stock. Trading patterns to watch: exercises/sales tied to equity vesting or tax funding (common when RSUs/options are used heavily), opportunistic sales when management cites near‑term liquidity needs, and buying/selling around order/ backlog disclosures, earnings, or material integration milestones for Incal. Regulatory and operational constraints (export controls, tariffs, IP disputes in China, and customer concentration) increase the chance that material non‑public developments will influence insider activity; investors should also check for 10b5‑1 plans and blackout‑period timing, since those plans are frequently used in small tech firms to provide pre‑scheduled liquidity while avoiding signaling.